Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-17-310542
Filing Date
2017-10-16
Accepted
2017-10-16 10:59:02
Documents
2
Group Members
MERCK SHARP & DOHME CORP.

Document Format Files

Seq Description Document Type Size
1 SC 13G d388662dsc13g.htm SC 13G 60770
2 EX-99.1 d388662dex991.htm EX-99.1 3967
  Complete submission text file 0001193125-17-310542.txt   66859
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filed by) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Subject) CIK: 0001348911 (see all company filings)

EIN.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: SC 13G | Act: 34 | File No.: 005-88797 | Film No.: 171137949
SIC: 2834 Pharmaceutical Preparations